GLP1R and type 2 diabetes mellitus: Glucagon-like peptide 1 receptor agonists (GLP-1 RA) mimic the action of endogenous GLP-1 in enhancing glucose-dependent insulin secretion and suppress glucagon production from pancreatic alpha cells and thus used to treat T2DM.